WALTHAM, Mass.--(BUSINESS WIRE)--After the recently announced union of DENTSPLY Friadent and Astra Tech Dental into the new company DENTSPLY Implants, DENTSPLY Implants North America announces its first product release with the expansion of the ATLANTIS™ patient-specific abutment solution to include availability for the ANKYLOS® Implant System for US and Canadian customers.

ATLANTIS™ Abutments in titanium and gold-shaded titanium for ANKYLOS® are the latest additions to the ongoing development of the patient-specific abutment assortment. ATLANTIS™ Abutments are already available in over 50 interfaces, including all major implant systems from DENTSPLY Implants, Straumann, Nobel Biocare, Biomet 3i and Zimmer Dental.

For a copy of the ATLANTIS™ compatibility chart, visit

About ATLANTIS™ abutments

ATLANTIS™ abutments are designed and fabricated using ATLANTIS VAD™ (Virtual Abutment Design) software, a patented process that combines state-of-the-art 3D optical scanning, advanced software and manufacturing methods to deliver patient-specific abutments that eliminates the need for hand modification. ATLANTIS™ abutments help to expand the possibilities for cement-retained implant restorations and are available for all major implant systems and in titanium, gold-shaded titanium and five shades of zirconia, including a translucent white zirconia available for their single-tooth, screw-retained ATLANTIS™ Crown Abutment.

ATLANTIS™ and ATLANTIS VAD™ are trademarks of DENTSPLY Implants. All other trademarks are the property of their respective owners.

About DENTSPLY Implants

DENTSPLY Implants is the union of two successful and innovative dental implant businesses: DENTSPLY Friadent and Astra Tech Dental. DENTSPLY Implants offers a comprehensive line of implants, including ASTRA TECH Implant System™, ANKYLOS® and XiVE®, digital technologies such as ATLANTIS™ patient-specific abutments, and regenerative bone products and professional development programs. DENTSPLY Implants creates value for dental professionals, and allows for predictable and lasting implant treatment outcomes, resulting in enhanced quality of life for patients. For more information, visit